Mitochondrial Genomic Alterations in Pediatric Acute Lymphoblastic Leukemia: Implications for Methotrexate‐Induced Neurotoxicity and Ethnic Disparities
Cancer Medicine · 2026
DOI: 10.1002/cam4.72315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Jing Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Methotrexate, DNA, Mitochondrial, Antimetabolites, Antineoplastic. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, Cancer Prevention and Research Institute of Texas, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Methotrexate (MTX)‐induced neurotoxicity is a serious complication in pediatric acute lymphoblastic leukemia (ALL), with observed ethnic disparities in risk. To investigate the role of mitochondrial DNA (mtDNA) variation, we performed whole mtDNA sequencing in 94 children with ALL, including 62 Hispanic patients. We identified 1294 mtDNA variants, including 12.4% novel variants, with MT‐ND5 and the D‐loop representing major variant hotspots. Gene‐based analyses identified significant associations of MT‐ND6 and MT‐ND2 with MTX neurotoxicity after multiple testing correction. Heteroplasmy was more frequent in affected patients, and predictive models incorporating mtDNA variants improved discrimination (AUC = 0.78) compared with clinical factors alone. These findings suggest that mtDNA variation, particularly involving Complex I genes, may contribute to MTX neurotoxicity and support its potential utility for risk stratification, while requiring validation in independent cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Public Health, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Cancer Center Biostatistics Shared Resource, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be the Match, Minneapolis, Minnesota, USA.
- Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
ORCID-Profile: Shahram Arsang-Jang, Paul L Auer, Wael Saber, Raul Urrutia, Xiaowu Gai, Philip Lupo, Michael Scheurer, Jing Dong
Förderung
- NHLBI NIH HHS
- Cancer Prevention and Research Institute of Texas
- National Heart, Lung, and Blood Institute
Zitieren
APA
Han, J., Arsang-Jang, S., Auer, P. L., Saber, W., Michaelis, L., Urrutia, R., Gai, X., Lupo, P., Scheurer, M., & Dong, J. (2026). Mitochondrial Genomic Alterations in Pediatric Acute Lymphoblastic Leukemia: Implications for Methotrexate‐Induced Neurotoxicity and Ethnic Disparities. Cancer Medicine. https://doi.org/10.1002/cam4.72315
Vancouver
Han J, Arsang-Jang S, Auer PL, Saber W, Michaelis L, Urrutia R, et al. Mitochondrial Genomic Alterations in Pediatric Acute Lymphoblastic Leukemia: Implications for Methotrexate‐Induced Neurotoxicity and Ethnic Disparities. Cancer Medicine. 2026. doi:10.1002/cam4.72315
BibTeX
@article{Han2026,
author = {Han, Jing and Arsang-Jang, Shahram and Auer, Paul L and Saber, Wael and Michaelis, Laura and Urrutia, Raul and Gai, Xiaowu and Lupo, Philip and Scheurer, Michael and Dong, Jing},
title = {Mitochondrial Genomic Alterations in Pediatric Acute Lymphoblastic Leukemia: Implications for Methotrexate‐Induced Neurotoxicity and Ethnic Disparities},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72315}
}
EUVIMED